3922
S. Kawaguchi et al. / Tetrahedron Letters 47 (2006) 3919–3922
11. In CDCl3, diphosphine 1 was gradually decomposed to
form chlorodiphenylphosphine (Ph2PCl; 31P NMR d 82.38
ppm; Appel, R.; Milker, R. Chem. Ber. 1975, 108, 1783.)
upon irradiation through Pyrex with a xenon lamp,
whereas no conversion of 1 to Ph2PCl was observed in
CD2Cl2 and benzene. Thus, CD2Cl2 and benzene are
suitable solvents for the reactions conducted under photo-
irradiation conditions.
12. Semenzin, D.; Etemad-mogha, G.; Albouy, D.; Diallo, O.;
Koenig, M. J. Org. Chem. 1997, 62, 2414.
13. The exclusive Z selectivity observed in the bisphosphin-
ation of phenylacetylene may arise from the interaction
between the alkyne and diphosphine in the ground or
excited state.
IR (NaC1, neat) 2925, 1436, 1098, 693, 643 cmꢀ1; HRMS
calcd for C32H34P2S2: 544.1577, found: 544.1573; Anal.
Calcd for C32H34P2S2: C, 70.56; H, 6.29%. Found: C,
1
70.36; H, 6.27%. [(E)-isomer] H NMR (CDCl3) d 0.71 (t,
J = 7.3 Hz, 3H), 0.81–0.82 (m, 4H), 0.88–0.90 (m, 2H),
0.96–1.00 (m, 2H), 2.67–2.75 (m, 2H), 7.24 (dd, J = 27.1,
20.0 Hz, 1H), 7.39–7.50 (m, 10H), 7.51–7.53 (m, 2H),
7.75–7.81 (m, 8H); 13C NMR (CDC13) d 13.77, 13.87,
22.15, 29.20, 29.30, 30.85, 128.53 (d, J = 14.4 Hz), 128.64
(d, J = 14.4 Hz), 130.92, 130.96 (d, J = 10.6 Hz), 131.19
(d, J = 83.4 Hz), 132.12 (d, J = 10.6 Hz), 132.23, 133.66
(d, J = 85.4 Hz), 135.93 (ddd, J = 72.9, 19.2, 8.6 Hz),
156.38 (d, J = 59.5 Hz); 31P NMR (CDC13) d 28.66 (d,
J = 56.7 Hz), 49.58 (d, J = 61.0 Hz); IR (NaCl, neat)
14. 31P NMR (CD2Cl2), 3a: For (E)-isomer, d ꢀ30.1 ppm (d,
J = 418 Hz), ꢀ14.35 ppm (d, J = 426 Hz); For (Z)-isomer,
d ꢀ25.20 ppm (d, J = 161 Hz), ꢀ6.02 ppm (d, J =
157 Hz). Compound 3b: For (E)-isomer, d ꢀ29.85 ppm
(d, J = 300 Hz), ꢀ13.55 ppm (d, J = 300 Hz); For (Z)-
isomer, d ꢀ24.50 ppm (d, J = 157 Hz), ꢀ5.90 ppm (d, J =
161 Hz). Compound 3c: For (E)-isomer, d ꢀ30.3 ppm (d,
J = 444 Hz), ꢀ14.35 ppm (d, J = 422 Hz); For (Z)-isomer,
d ꢀ24.80 ppm (d, J = 161 Hz), ꢀ6.75 ppm (d, J =
157 Hz). Compound 3d: d ꢀ24.55 ppm (d, J = 144 Hz),
ꢀ3.51 ppm (d, J = 144 Hz).
3054, 2926, 2854, 1435, 1100, 717, 692, 629, 614, 527 cmꢀ1
.
Compound 5c: [(Z)-isomer] 1H NMR (CDCl3) d 2.02–2.07
(m, 2H), 2.54–2.60 (m, 2H), 3.45 (t, J = 6.5 Hz, 2H), 7.00
(dd, J = 41.1, 12.8 Hz, 1H), 7.23–7.27 (m, 4H), 7.29–7.33
(m, 4H), 7.35–7.39 (m, 4H), 7.64–7.69 (m, 4H), 7.73–7.78
(m, 4H); 13C NMR (CDC13) d 33.67, 37.47 (t like,
J = 5.8 Hz), 43.84, 128.4 (d, J = 11.5 Hz), 128.5 (d, J =
11.5 Hz), 130.91 (d, J = 83.5 Hz), 131.02 (d, J = 15.4 Hz),
131.02 (d, J = 4.6 Hz), 132.36 (d, J = 15.4 Hz), 132.37 (d,
J = 6.7 Hz), 133.37 (d, J = 87.5 Hz), 136.10 (ddd,
J = 79.6, 10.6, 6.7 Hz), 150.47 (d, J = 69.2 Hz); 31P
NMR (CDC13) d 31.62 (d, J = 17.4 Hz), 42.13 (d, J =
17.4 Hz); IR (NaCl, neat) 3053, 1436, 1100, 910, 799, 692,
671, 613 cmꢀ1; HRMS calcd for C29H27ClP2S2: 536.0718,
found: 536.0714. Anal. Calcd for C29H27ClP2S2: C, 64.86;
H, 5.07%. Found: C, 63.99; H, 5.09%. [(E)-isomer] 1H
NMR (CDC13) d 1.43–1.49 (m, 2H), 2.83–2.93 (m, 2H),
3.11 (t,J = 6.7 Hz, 2H), 7.33 (dd, J = 25.4, 6.4 Hz, 1H),
7.42–7.50 (m, 10H), 7.53–7.56 (m, 2H), 7.74–7.80 (m, 8H);
13C NMR (CDC13) d 28.16 (t, J = 8.6 Hz), 31.97, 44.37 (t,
J = 7.7 Hz), 128.83 (d, J = 12.5 Hz), 128.86 (d, J =
12.5 Hz), 130.78 (d, J = 83.4 Hz), 130.98 (d, J = 10.5
Hz), 131.79, 132.12, 132.22 (d, J = 7.7 Hz), 133.44 (d,
J = 85.4 Hz), 137.14 (dt, J = 71.9, 8.6 Hz), 154.88 (d,
J = 60.4 Hz); 31P NMR (CDC13) d 28.42 (d, J = 56.7 Hz),
49.57 (d, J = 56.7 Hz); IR (NaCl, neat) 3053, 2330, 1437,
1099, 716, 691, 631, 613, 525, 496 cmꢀ1. Compound 5d:
[(Z)-isomer] 1H NMR (CDCl3) d 7.10 (dd, J = 26.1,
12.4 Hz, 1H), 7.06–7.40 (m, 17H), 7.61–7.78 (m, 8H); 13C
NMR (CDC13) d 127.96, 128.04, 128.19 (d, J = 11.5 Hz),
130.92 (d, J = 7.7 Hz), 131.11 (d, J = 3.0 Hz), 131.57 (d,
J = 15.3 Hz), 131.57 (d, J = 5.7 Hz), 131.76 (d, J = 85.4
Hz), 131.95 (d, J = 17.2 Hz), 131.95 (d, J = 3.8 Hz),
132.69 (d, J = 87.3 Hz), 138.98 (ddd, J = 74.8, 11.5,
10.5 Hz), 141.89 (dd, J = 16.3, 10.5 Hz), 150.78 (d, J =
69.0 Hz); 31P NMR (CDCl3) d 32.74 (d, J = 13.0 Hz),
38.38 (d, J = 13.0 Hz); IR (neat) 3053, 1436, 1097, 738,
717, 694, 644, 516 cmꢀ1; HRMS calcd for C32H26P2S2:
536.0951, found: 536.0955. Anal. Calcd for C32H26P2S2:
C, 71.62; H, 4.88%. Found: C, 71.86; H, 5.12%.
1
15. Compound 5a: [(Z)-isomer] H NMR (CDCl3) d 0.70 (d,
J = 6.4 Hz, 6H), 1.19–1.47 (m, 3H), 2.34–2.39 (m, 2H),
6.96 (dd, J = 41.7, 12.4 Hz, 1H), 7.24–7.76 (m, 20H); 13C
NMR (CDCl3) d 22.18, 27.86, 37.82, 39.75, 128.22, 128.32,
131.27 (d, J = 17.2 Hz), 131.27 (d, J = 4.7 Hz), 131.34 (d,
J = 83.7 Hz), 132.37 (d, J = 16.3 Hz), 132.37 (d, J =
5.7 Hz), 133.59 (d, J = 87.3 Hz), 134.88 (ddd, J = 82.5,
12.5, 11.5 Hz), 152.46 (d, J = 65.2 Hz); 31P NMR (CDCl3)
d 32.11 (d, J = 17.4 Hz), 42.28 (d, J = 17.4 Hz); IR (NaCl,
neat) 2952, 1436, 1097, 705, 692, 642 cmꢀ1; HRMS calcd
for C31H32P2S2: 530.1421, found: 530.1418; Anal. Calcd
for C31H32P2S2: C, 70.16; H, 6.08%. Found: C, 69.96; H,
6.04%. [(E)-isomer] 1H NMR (CDCl3)
d 0.46 (d,
J = 5.0 Hz, 6H), 0.99–1.07 (m, 2H), 1.19–1.22 (m, 1H),
2.69–2.73 (m, 2H), 7.34 (dd, J = 27.0, 20.2 Hz, 1H), 7.40–
7.84 (m, 20H); 13C NMR (CDCl3) d 21.75, 28.37, 29.05,
37.56, 128.62 (d, J = 9.5 Hz), 128.70 (d, J = 9.5 Hz),
131.04 (d, J = 7.6 Hz), 131.34 (d, J = 83.4 Hz), 131.54,
131.87, 132.26 (d, J = 9.5 Hz), 133.73 (d, J = 85.4 Hz),
136.36 (dt, J = 72.9, 9.6 Hz), 156.71 (d, J = 60.4 Hz); 31P
NMR (CDCl3)
d 28.60 (d, J = 61.0 Hz), 49.55 (d,
J = 61.0 Hz); IR (NaCl, neat) 2954, 2358, 2341, 1436,
1099, 715, 692 cmꢀ1; 5b: [(Z)-isomer] 1H NMR (CDCl3) d
0.80 (t, J = 7.3 Hz, 3H), 1.21–1.23 (m, 6H), 1.54–1.60 (m,
2H), 2.34–2.41 (m, 2H), 6.94 (dd, J = 41.7, 12.7 Hz, 1H),
7.22–7.32 (m, 8H), 7.33–7.38 (m, 4H), 7.66–7.77 (m, 8H);
13C NMR (CDC13) d 13.88, 22.37, 28.67, 30.57, 31.23,
39.65, 128.09 (d, J = 12.5 Hz), 128.32 (d, J = 12.5 Hz),
131.12 (d, J = 16.3 Hz), 131.12 (d, J = 4.8 Hz), 131.26 (d,
J = 83.5 Hz), 132.28 (d, J = 15.6 Hz), 132.28 (d,
J = 5.7 Hz), 133.59 (d, J = 86.3 Hz), 134.65 (ddd, J =
81.5, 9.6, 7.7 Hz), 152.20 (d, J = 68.1 Hz);31P NMR
(CDC13) d 31.90 (d, J = 17.4 Hz), 42.28 (d, J = 17.4 Hz);
16. (a) Yasui, S.; Shioji, K.; Yoshihara, M.; Maeshita, T.;
Ohno, A. Bull. Chem. Soc. Jpn. 1993, 66, 2077; (b) Renard,
P.-Y.; Vayron, P.; Leclerc, E.; Valleix, A.; Miskowski, C.
Angew. Chem., Int. Ed. 2003, 42, 2389.